Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1823-1832
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1823
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1823
Table 1 Comparison of general information of ulcer group and non-ulcer group, n (%)
General Information | Ulcer group (n = 40) | Non-ulcer group (n = 156) | t/χ2 value | P value |
Sex | 0.83 | 0.362 | ||
Male | 26 (65.00) | 89 (57.05) | ||
Female | 14 (35.00) | 67 (42.95) | ||
Age | 48.98 ± 8.23 | 47.11 ± 9.02 | 1.257 | 0.213 |
BMI | 22.25 ± 2.01 | 21.83 ± 1.98 | 1.183 | 0.242 |
Course of disease (yr) | 2.85 ± 0.48 | 2.66 ± 0.52 | 2.195 | 0.032 |
History of H. pylori infection | 7 (17.50) | 11 (7.05) | 4.168 | 0.041 |
Family history of GC | 8 (20.00) | 22 (14.10) | 0.854 | 0.355 |
Drinking history | 9 (22.50) | 26 (16.67) | 0.739 | 0.39 |
Smoking history | 24 (60.00) | 66 (42.31) | 4.013 | 0.045 |
Comorbidities | ||||
Hypertension | 9 (22.50) | 26 (16.67) | 0.739 | 0.39 |
Diabetes | 6 (15.00) | 22 (14.10) | 0.021 | 0.885 |
Coronary heart disease | 7 (17.50) | 23 (14.75) | 0.187 | 0.666 |
Residence | 0.116 | 0.733 | ||
Rural | 25 (62.50) | 102 (65.38) | ||
Town | 15 (37.50) | 54 (34.62) | ||
Medication history | ||||
Aspirin | 12 (30.00) | 28 (17.95) | 2.847 | 0.092 |
Clopidogrel | 19 (47.50) | 27 (17.31) | 16.158 | < 0.001 |
Table 2 Comparison of pathological features of ulcer group and non-ulcer group, n (%)
Pathological features | Ulcer group (n = 40) | Non-ulcer group (n = 156) | t/χ2 value | P value |
Lesion diameter (cm) | 4.40 ± 0.97 | 2.97 ± 0.62 | 8.871 | < 0.001 |
Number of tumors | 4.185 | 0.041 | ||
Single shot | 18 (45.00) | 98 (62.83) | ||
Multiple | 22 (55.00) | 58 (37.18) | ||
Pathological type | 0.268 | 0.605 | ||
Differentiated carcinoma | 19 (47.50) | 67 (42.95) | ||
Undifferentiated carcinoma | 21 (52.50) | 89 (57.05) | ||
Infiltration depth | 3.988 | 0.046 | ||
Submucosa | 21 (52.50) | 55 (35.26) | ||
Mucosal layer | 19 (47.50) | 101 (64.74) | ||
Vascular invasion | 2 (5.00) | 6 (3.85) | 0.108 | 0.742 |
Table 3 Comparison of endoscopic features of ulcer group and non-ulcer group, n (%)
Endoscopic features | Ulcer group (n = 40) | Non-ulcer group (n = 156) | χ2 value | P value |
Lesion site | 2.132 | 0.344 | ||
Upper 1/3 of stomach | 12 (30.00) | 61 (39.10) | ||
1/3 of stomach | 20 (50.00) | 76 (48.72) | ||
Lower 1/3 of stomach | 8 (20.00) | 19 (12.18) | ||
Mucosal discoloration | 28 (70.00) | 63 (40.38) | 11.227 | < 0.001 |
Convergence folds | 28 (60.00) | 49 (31.41) | 19.877 | < 0.001 |
Lesion surface | 1.105 | 0.576 | ||
Bulge | 11 (27.50) | 52 (33.33) | ||
Flat | 15 (37.50) | 62 (39.74) | ||
Sag | 14 (35.00) | 42 (26.93) |
Table 4 Multivariate logistic regression analysis on the risk of ulcers after endoscopic submucosal dissection in early gastric cancer patients
Related indicator | β | SE | Wald | P value | OR | 95%CI | |
Lower | Upper | ||||||
Lesion diameter | 3.417 | 0.647 | 27.927 | < 0.001 | 30.490 | 8.584 | 108.294 |
Clopidogrel medication history | 1.268 | 0.642 | 3.899 | 0.048 | 3.554 | 1.009 | 12.515 |
Convergent folds | 1.351 | 0.659 | 4.195 | 0.041 | 3.860 | 1.060 | 14.055 |
Mucosal discoloration | 1.160 | 0.584 | 3.950 | 0.047 | 3.191 | 1.016 | 10.021 |
Table 5 Evaluation of prediction model for ulcer occurrence after endoscopic submucosal dissection in early gastric cancer patients
Indicator | AUC | SD | P value | 95%CI | |
Lower | Upper | ||||
Lesion diameter | 0.885 | 0.036 | < 0.001 | 0.814 | 0.955 |
Clopidogrel medication history | 0.651 | 0.052 | 0.003 | 0.549 | 0.753 |
Mucosal discoloration | 0.648 | 0.048 | 0.004 | 0.554 | 0.742 |
Convergent folds | 0.693 | 0.047 | < 0.001 | 0.601 | 0.785 |
Prediction model | 0.916 | 0.026 | 0.000 | 0.865 | 0.967 |
- Citation: Gong SD, Li H, Xie YB, Wang XH. Construction and analysis of an ulcer risk prediction model after endoscopic submucosal dissection for early gastric cancer. World J Gastrointest Oncol 2022; 14(9): 1823-1832
- URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1823.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1823